TrialFrontiers in endocrinology2022

The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.

Yan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.